Consultancy to support TB/HIV Activities (2016/HTM/HIV/003)

WHO
Consultancy to support TB/HIV Activities (2016/HTM/HIV/003) Request for proposal

Reference: 2016/HTM/HIV/003
Beneficiary countries or territories: Switzerland
Published on: 10-Feb-2016
Deadline on: 01-Mar-2016 12:00 (GMT 1.00)

Description

The WHO programme on HIV is located in the HIV, TB and Malaria Cluster (HTM). The HIV and Hepatitis programme is guided by the Global Health Strategies for HIV and Hepatitis 2016-21. The new strategies are submitted to the Executive Board and World Assembly in respectively January and May 2016 for approval.  The goal of the Secretariat’s draft strategy on HIV and Viral Hepatitis is to end the AIDS epidemic as a public health threat by 2030, within the context of ensuring healthy lives and promoting well-being for all at all ages. Furthermore, it is aligned with the 2030 Agenda for Sustainable Development: its focus is on ensuring financial security and health equity through its commitment to universal health coverage.

                                                      

The contractor will work with the Treatment and Care (TAC) Team within the HIV Department.

 

Main Tasks:

  1. Support the TB/HIV Global Task Force to review TB/HIV activities and identify innovative responses to country level implementation of WHO guidelines and recommendations developed under the TB/HIV collaborative activities framework.
  2. Assist with preparations for relevant conferences in collaboration with Global TB programme: 47th Union world conference on lung health 2016, Global TB conference TB2016.
  3. Provide technical input into HIV department regional and country level dissemination and capacity building activities of the WHO 2015 consolidated guidelines on the use of antiretrovirals for treating and preventing HIV infection
  4. Provide technical support to in-country reviews and intensified technical assistance plans of key countries identified (4-5) following reports on adoption of policy and implementation.
  5. Provide technical support for the review of TB and HIV concept notes for the Global Fund in high priority countries.
  6. Compile, verify and analyse the routine TB/HIV M&E data collection in coordination with the Global TB programme and UNAIDS.
  7. Support the development of a package of care and interventions for persons with advanced disease to reduce mortality from HIV-associated TB, including guidance on presumptive TB treatment and LF-LAM in the care package for late presenters.
  8. Strengthen country implementation monitoring of TB infection control in health facilities in 3-4 countries of extremely high burden of HIV-associated TB.            
  9. Draft the final detailed plan and report on the 2015 plan and implementation on the consultancy which can be used by the coordinator of TAC for work plan and donor reporting.
  10. Provide regular draft communication updates for key TB/HIV stakeholders, including CDC, USAID and PEPFAR.

 

Key requirements for this consultancy:

 

Essential Education:

 

  • Medical Doctor Degree or Master in Public Health 

 

Essential Work experience:

 

  • Essential: At least 7 years working experience in the field of infectious diseases of which two years in TB/HIV.

 

The work is estimated for a period of 12 months (20 days per month). The consultancy may be prolonged up to 24 months depending on performance and funding availability.

 

Submission of proposals:

No later than 1 March 2016, 12:00 (CET), the bidder shall complete and return by either email or hard copy to WHO (only when this step is completed the bidder is regarded as a prospective bidder):

 

  1. Covering letter signed by the bidder or the respective authority when the bidder is not an individual.
  2. Proposal (including, but not restricted to, technical and financial documents).
  3. “2016HTMHIV003_3_RFP Confidentiality Undertaking (TAC TB/HIV)” form completed/signed.
  4. “2016HTMHIV003_4_RFP Acknowledgement Form (TAC TB/HIV)” form completed/signed as confirmation of the bidder's intention to submit a bona fide proposal and designate its representative to whom communications may be directed, including any addenda.
  5. “2016HTMHIV003_5_ RFP Acceptance Form (TAC TB/HIV)” form completed/signed.
  6. “2016HTMHIV003_6_RFP Completeness Form (TAC TB/HIV)” form completed/signed.

A prospective bidder requiring any clarification on technical, contractual or commercial matters may notify WHO via email at the following address no later than 23 February 2016, 12:00 CET.

 

  • Email for submissions of forms and/or proposal: pdifin@who.int (use subject: Bid Ref 2016HTMHIV003)
  • Mailing address for submission of proposal:

World Health Organization

­­­­Mr. Jerome Peron

HQ/HIV, PDI/FIN, D45034

Bid Ref: 2016HTMHIV003

20, Avenue Appia

CH-1211 Geneva 27

               

Refer to attached documents for additional information.